281 related articles for article (PubMed ID: 25893546)
1. Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers.
Bozkurt O; Eras Z; Canpolat FE; Oguz SS; Uras N; Dilmen U
J Matern Fetal Neonatal Med; 2016; 29(7):1101-4. PubMed ID: 25893546
[TBL] [Abstract][Full Text] [Related]
2. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
3. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
4. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.
Havranek T; Ashmeade TL; Afanador M; Carver JD
Neonatology; 2011; 100(1):44-9. PubMed ID: 21212694
[TBL] [Abstract][Full Text] [Related]
5. Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children.
Gentle SJ; Carlo WA; Tan S; Gargano M; Ambalavanan N; Chawla S; Bell EF; Bann CM; Hintz SR; Heyne RJ; Tita A; Higgins RD;
Obstet Gynecol; 2020 Jun; 135(6):1377-1386. PubMed ID: 32459430
[TBL] [Abstract][Full Text] [Related]
6. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
7. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.
Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB
Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199
[TBL] [Abstract][Full Text] [Related]
8. Antenatal magnesium sulfate and neuroprotection.
Doyle LW
Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
[TBL] [Abstract][Full Text] [Related]
9. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.
Leviton A; Paneth N; Susser M; Reuss ML; Allred EN; Kuban K; Sanocka U; Hegyi T; Hiatt M; Shahrivar F; Van Marter LJ
Pediatrics; 1997 Apr; 99(4):E2. PubMed ID: 9099777
[TBL] [Abstract][Full Text] [Related]
10. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
11. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
Nelson KB; Grether JK
Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
[TBL] [Abstract][Full Text] [Related]
12. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia.
Murata Y; Itakura A; Matsuzawa K; Okumura A; Wakai K; Mizutani S
Brain Dev; 2005 Jan; 27(1):17-21. PubMed ID: 15626536
[TBL] [Abstract][Full Text] [Related]
13. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
Marret S; Ancel PY
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
[TBL] [Abstract][Full Text] [Related]
14. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
Costantine MM; Drever N
Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
[TBL] [Abstract][Full Text] [Related]
15. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
16. Protection of brain development by antenatal magnesium sulphate for infants born preterm.
Chollat C; Sentilhes L; Marret S
Dev Med Child Neurol; 2019 Jan; 61(1):25-30. PubMed ID: 30294845
[TBL] [Abstract][Full Text] [Related]
17. Antenatal magnesium sulfate and intestinal morbidities in preterm infants with extremely low gestational age.
Kim SH; Kim YJ; Shin SH; Cho H; Shin SH; Kim EK; Kim HS; Hong S; Lee SM
Pediatr Neonatol; 2021 Mar; 62(2):202-207. PubMed ID: 33495105
[TBL] [Abstract][Full Text] [Related]
18. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
19. Antenatal magnesium sulfate: Neuro-protection for preterm infants.
Oddie S; Tuffnell DJ; McGuire W
Arch Dis Child Fetal Neonatal Ed; 2015 Nov; 100(6):F553-7. PubMed ID: 25896966
[TBL] [Abstract][Full Text] [Related]
20. Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
Robbins LS; Blanchard CT; Sinkey RG; Harris SL; Tita AT; Harper LM
Am J Perinatol; 2021 Feb; 38(3):218-223. PubMed ID: 32862421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
